RDEA3170 Bioavailability Study

NCT02336594 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: RDEA3170 10 mg
DRUG: RDEA3170 2.5 mg

Sponsor

Ardea Biosciences, Inc.